Donor cells battle Post-Transplant cancer in major trial
NCT ID NCT00033475
Summary
This study tested whether adding specially prepared donor white blood cells to a reduction in anti-rejection drugs works better than just reducing the drugs alone. It involved 50 people who developed a type of cancer linked to Epstein-Barr virus after receiving a heart, lung, liver, or kidney transplant. The goal was to see if the donor cells could help control the cancer and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOPROLIFERATIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Birmingham Children's Hospital
Birmingham, England, B4 6NH, United Kingdom
-
Central Manchester and Manchester Children's University Hospitals NHS Trust
Manchester, England, M27 4HA, United Kingdom
-
Institute of Cancer Research - UK
Sutton, England, SM2 5NG, United Kingdom
-
King's College Hospital
London, England, SE5 8RX, United Kingdom
-
Northern General Hospital
Sheffield, England, S5 7AU, United Kingdom
-
Papworth Hospital
Cambridge, England, CB3 8RE, United Kingdom
-
Royal Free and University College Medical School
London, England, NW3 2PF, United Kingdom
-
Royal Infirmary - Castle
Glasgow, Scotland, G4 0SF, United Kingdom
-
Royal Infirmary of Edinburgh at Little France
Edinburgh, Scotland, EH16 4SA, United Kingdom
-
University of Edinburgh
Edinburgh, Scotland, EH8 1QH, United Kingdom
-
University of Edinburgh Laboratory for Clinical and Molecular Virology
Edinburgh, Scotland, EH9 1QH, United Kingdom
-
Wythenshawe Hospital
Manchester, England, M23 9LJ, United Kingdom
Conditions
Explore the condition pages connected to this study.